Open Access Open Access  Restricted Access Subscription or Fee Access

Ballon Condom Tamponade

Manjot Kaur

Abstract


In order to encounter the Millennium Development Goals , we must attain a decrease in the demises due to postpartum haemorrhage (PPH) which is the main donor in the emerging countries. As per WHO recommendations, the use of intrauterine balloon tamponade (UBT) is recommended for the treatment of PPH due to uterine atony if women do not respond to uterotonics . FIGO also comprised uterine balloon tamponade as a suggested second-line interference for the conduct of PPH. The fruitful outcome of inflatable tamponade is described to be 80–100 %. This high efficacy avoids surgery which is often delayed or may be unavailable thereby costing the women her life. Intrauterine balloon may also be used as a delaying amount while expecting transference or to resuscitate her. The commercially available uterine-specific devices are designed with an intrauterine drainage port but have a prohibitively high cost. Low reserve settings have to trust on inferior cost versions like condom balloon tamponade which is the most cost-effective second-line organization choice . q

Full Text:

PDF

References


Trends in maternal mortality: 1990 to 2010. WHO, UNICEF, UNFPA and The World Bank estimates. Geneva: WHO; 2012. http://whqlibdoc.who.int/publications/2012/9789241503631_eng.pdf. Last accessed 1 Sept 2012.

Countdown to 2015: maternal, newborn and child survival [Internet]. WHO and UNICEF; 2012. http://www.countdown2015mnch.org/documents/2012Report/2012-Complete.pdf. Last accessed 1 Sept 2012.

World Health Organization (WHO) WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization (WHO); 2012.

FIGO FIGO guidelines: prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;117:108–118. doi: 10.1016/j.ijgo.2012.03.001. [PubMed] [Cross Ref]

Georgiou C. A review of current practice in using Balloon Tamponade Technology in the management of postpartum haemorrhage. Hypertens Res Pregnancy. 2014;2:1–10. doi: 10.14390/jsshp.2.1. [Cross Ref]

Ranathunga GA. Post partum haemorrhage, severe acute maternal morbidity and the condom catheter uterine tamponade. Sri Lanka J Obstet Gynaecol. 2013;35(4):100–11.

Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum haemorrhage today: ICM/FIGO initiative 2004‐2006. Int J Gynaecol Obstet 2006;94:243–53.

World Health Organization. Attending to 136 million births, every year: make every mother and child count: chapter 4: risking death to give life. The World Health Report 2005.Geneva, Switzerland: WHO; 2005.

Liston W. Haemorrhage. In: Lewis G, editor. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer—2003‐2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH; 2007. pp. 78–85.

Sullivan EA, Hall B, King JF. Maternal Deaths in Australia 2003‐2005. Maternal Deaths Series No. 3 Cat. no. PER 42. Sydney, Australia: AHW National Perinatal Statistics Unit, 2007.

Use of a Condom to Control Massive Postpartum Hemorrhage https://www.medscape.com




DOI: https://doi.org/10.37628/ijnspr.v4i2.817

Refbacks

  • There are currently no refbacks.